Frontotemporal Dementia With Progranulin Mutations Ftd Grn clinical trials

Explore recruiting frontotemporal dementia with progranulin mutations ftd grn clinical trials.

Recruiting frontotemporal dementia with progranulin mutations ftd grn studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Frontotemporal Dementia With Progranulin Mutations Ftd Grn trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Open-Label, Ascending Dose, Multicentre Study to Evaluate the Safety and Preliminary Efficacy of AVB-101 Administered by Bilateral Intrathalamic Infusion in Subjects With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)

Sweden, Spain, Belgium, Netherlands, Italy, Poland

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Frontotemporal Dementia With Progranulin Mutations Ftd Grn trials by city

Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Toronto Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Vancouver Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Montreal Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Calgary Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Edmonton Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Ottawa Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Winnipeg Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Quebec City Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Hamilton Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Kitchener Frontotemporal Dementia With Progranulin Mutations Ftd Grn in London Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Halifax Frontotemporal Dementia With Progranulin Mutations Ftd Grn in New York Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Los Angeles Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Chicago Frontotemporal Dementia With Progranulin Mutations Ftd Grn in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease